Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California
California jury agreed that Boehringer Ingelheim's heartburn drug was dangerous, but was split on whether Zantac caused the bladder cancer diagnosis.
Tag Archives: Boehringer Ingelheim
-
-
Federal Appeals Court Returns Zantac Cancer Lawsuits Back To Connecticut State Court
Judges noted that the nine Zantac lawsuits involving more than 850 plaintiffs were structured in a way to avoid the need for the cases to be handled at the federal level, where all similar claims have been dismissed.
-
Jury Rejects Claim That Zantac Caused Cancer Diagnosis in First Bellwether Trial
Verdict comes in a Zantac lawsuit against GlaxoSmithKline and Boehringer Ingelheim, weeks after Sanofi and Pfizer announced agreements to settle thousands of Zantac cancer claims.
-
Zantac Jury Trial Over Colorectal Cancer Diagnosis Gets Underway in Illinois
Jury is hearing evidence after several prior Zantac cancer lawsuits were settled weeks before trial was set to begin in other courts.
-
Zantac Cancer Lawsuit Payouts To Provide $25K Average Per Claim In Sanofi Settlement: Report
Sanofi will pay $100 million to resolve about 4,000 claims over toxic chemicals in the recalled heartburn drug, but tens of thousands of additional Zantac cancer lawsuits remain unsettled, with most pending in Delaware state court.
-
Zantac Settlement Agreement Reached in 4,000 Lawsuits Filed in U.S. State Courts
Deal comes as a Delaware judge is currently weighing whether to accept or reject plaintiffs' expert witness testimony in more than 70,000 other Zantac lawsuits still pending in that state.
-
Another California Zantac Lawsuit Settlement Reached Before Trial
Second time in the last month GlaxoSmithKline has reached a Zantac settlement agreement just before a case was set to go before a jury, privately resolving claims that the recalled heartburn drug caused cancer
-
Zantac Lawsuit Settlement Reached Before Upcoming California Trial
Although GlaxoSmithKline has agreed to several Zantac settlements payouts in recent months, the drug maker indicates that it plans to continue defending against cancer lawsuits being pursued by former users of Zantac.
-
Manufacturers Seeks Dismissal of Zantac Lawsuits in Delaware State Court
GlaxoSmithKline, Boehringer Ingelheim, Pfizer and other drug makers face more than 70,000 Zantac cancer lawsuits in Delaware state court, after a U.S. District Judge dimissed all claims filed in the federal court system in 2022.
-
More Zantac Cancer Settlements Reached by GlaxoSmithKline to Resolve State-Court Lawsuits
Settlement resolves four Zantac cancer lawsuits selected for bellwether trials in California, the first of which was expected to go before a jury begin in November.
